Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1182

1.

Extensively drug-resistant tuberculosis in california, 1993-2006.

Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J.

Clin Infect Dis. 2008 Aug 15;47(4):450-7. doi: 10.1086/590009.

PMID:
18616396
2.

Extensively drug-resistant tuberculosis: new strains, new challenges.

Banerjee R, Schecter GF, Flood J, Porco TC.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713. Review.

PMID:
18847407
3.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

4.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
5.

Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.

Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, Paramasivan CN, Narayanan PR, Sahu S, Parmar M, Chadha S, Dewan P, Chauhan LS.

Int J Tuberc Lung Dis. 2009 Sep;13(9):1154-60.

PMID:
19723407
6.

Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India.

Datta BS, Hassan G, Kadri SM, Qureshi W, Kamili MA, Singh H, Manzoor A, Wani MA, Shamas-u-Din, Thakur N.

J Infect Dev Ctries. 2009 Nov 21;4(1):19-23.

7.

Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.

Porwal C, Kaushik A, Makkar N, Banavaliker JN, Hanif M, Singla R, Bhatnagar AK, Behera D, Pande JN, Singh UB.

PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.

8.

Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.

Lai CC, Tan CK, Huang YT, Chou CH, Hung CC, Yang PC, Luh KT, Hsueh PR.

Clin Infect Dis. 2008 Oct 1;47(7):e57-63. doi: 10.1086/591702.

PMID:
18715157
9.

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Clin Infect Dis. 2007 Nov 15;45(10):1290-5. Epub 2007 Oct 15.

PMID:
17968823
10.

First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.

Paramasivan CN, Rehman F, Wares F, Sundar Mohan N, Sundar S, Devi S, Narayanan PR.

Int J Tuberc Lung Dis. 2010 Feb;14(2):243-6.

PMID:
20074419
11.

Extensively drug-resistant tuberculosis--United States, 1993-2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2007 Mar 23;56(11):250-3.

12.

Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control.

Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C.

Clin Chest Med. 2009 Dec;30(4):637-65, vii. doi: 10.1016/j.ccm.2009.08.015. Review.

PMID:
19925959
13.

Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.

Mlambo CK, Warren RM, Poswa X, Victor TC, Duse AG, Marais E.

Int J Tuberc Lung Dis. 2008 Jan;12(1):99-104.

PMID:
18173885
14.

Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.

Qi YC, Ma MJ, Li DJ, Chen MJ, Lu QB, Li XJ, Li JL, Liu W, Cao WC.

PLoS One. 2012;7(2):e32103. doi: 10.1371/journal.pone.0032103. Epub 2012 Feb 22.

15.

Extensively drug-resistant tuberculosis: current challenges and threats.

Jain A, Mondal R.

FEMS Immunol Med Microbiol. 2008 Jul;53(2):145-50. doi: 10.1111/j.1574-695X.2008.00400.x. Epub 2008 May 8. Review.

16.

Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics.

Minion J, Gallant V, Wolfe J, Jamieson F, Long R.

PLoS One. 2013;8(1):e53466. doi: 10.1371/journal.pone.0053466. Epub 2013 Jan 9.

17.

Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.

Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.

Int J Tuberc Lung Dis. 2006 Aug;10(8):844-50.

PMID:
16898367
18.

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.

Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.

19.

Multidrug- and extensively drug-resistant tuberculosis, Germany.

Eker B, Ortmann J, Migliori GB, Sotgiu G, Muetterlein R, Centis R, Hoffmann H, Kirsten D, Schaberg T, Ruesch-Gerdes S, Lange C; German TBNET Group.

Emerg Infect Dis. 2008 Nov;14(11):1700-6. doi: 10.3201/eid1411.080729.

20.

Extensively drug-resistant (XDR) tuberculosis: an old and new threat.

Fattorini L, Migliori GB, Cassone A.

Ann Ist Super Sanita. 2007;43(4):317-9. Review.

Supplemental Content

Support Center